Share
Market Research Report

ANTIPSYCHOTIC DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By DiseaseSchizophrenia · Bipolar Disorder · Unipolar Depression · Dementia · Others
  • By DrugRisperidone · Quetiapine · Olanzapine · Aripiprazole · Brexpiprazole · Paliperidone Palmitate · Others
  • By Therapeutic ClassFirst Generation · Second Generation · Third Generation
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · Online Pharmacies
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East · and Africa
  • Published In08 May 2026
  • Report CodeCMI1196
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Disease
      • Market Snippet, By Drug
      • Market Snippet, By Therapeutic Class
      • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario
  4. Global Antipsychotic Drugs Market, By Disease, 2021– 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Schizophrenia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Bipolar Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Unipolar Depression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Dementia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
  5. Global Antipsychotic Drugs Market, By Drug, 2021 – 2033 (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Risperidone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Quetiapine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Olanzapine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Aripiprazole
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Brexpiprazole
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Paliperidone Palmitate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
  6. Global Antipsychotic Drugs Market, By Therapeutic Class 2021– 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • First Generation
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Second Generation
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Third Generation
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
  7. Global Antipsychotic Drugs Market, By Distribution Channel 2021– 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
  8. Global Antipsychotic Drugs Market, By Region, 2021– 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
    • North America
      • Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
      • Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape

    • Company Profiles
      • H. Lundbeck A/S
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Otsuka Pharmaceutical Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Janssen Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Eli Lilly and Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • AbbVie, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Dr. Reddy’s Laboratories Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sumitomo Pharma Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Alkermes
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bristol-Myers Squibb Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  10. Section

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 24 market data tables and 20 figures on “Antipsychotic Drugs – Global forecast to 2033.